Longboard Pharmaceuticals Inc (LBPH) Stock Balance Sheet
NASDAQ:LBPH - Nasdaq - US54300N1037 - Common Stock - Currency: USD
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | N/A | N/A | N/A | 55.30M | |||
| Cash Equivalents | 27.61M | 14.33M | 10.80M | 66.30M | N/A | |||
| Marketable Securities | 260.84M | 34.17M | 56.80M | 40.40M | N/A | |||
| Other Current Assets | 4.58M | 1.72M | 2.20M | 1.70M | 0.00 | |||
| Total Current Assets | 293.03M | 50.22M | 69.80M | 108.40M | 55.40M | |||
| Non-Current Assets | ||||||||
| PPE Net | 3.73M | 476.00K | 700.00K | 500.00K | N/A | |||
| Other Non-Current Assets | 244.00K | 0.00 | 0.00 | 0.00 | 900.00K | |||
| Total Non-Current Assets | 3.98M | 476.00K | 800.00K | 600.00K | 800.00K | |||
| TOTAL ASSETS | 297.00M | 50.70M | 70.60M | 109.00M | 56.20M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 17.19M | 8.77M | 7.50M | 4.40M | 1.90M | |||
| Accounts Payable | 1.13M | 1.00M | 1.30M | 1.00M | 1.20M | |||
| Other Current Liabilities | 30.00K | N/A | N/A | N/A | N/A | |||
| Total Current Liabilities | 18.35M | 9.77M | 8.80M | 5.40M | 3.10M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 3.47M | 0.00 | 400.00K | 200.00K | N/A | |||
| Total Non-Current Liabilities | 3.47M | 0.00 | 300.00K | 200.00K | 0.00 | |||
| TOTAL LIABILITIES | 21.82M | 9.77M | 9.10M | 5.60M | 3.10M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -201.88M | -140.56M | -86.10M | -42.20M | -14.40M | |||
| Additional Paid In Capital | 476.36M | 181.56M | 148.30M | 145.70M | 11.70M | |||
| Common Shares | 3.00K | 2.00K | 0.00 | 0.00 | 55.80M | |||
| Other Shareholders' Equity | 700.00K | -78.00K | -700.00K | -200.00K | N/A | |||
| Shares Outstanding | 39.03M | 24.52M | 17.20M | 17.10M | 16.90M | |||
| Tangible Book Value per Share | 7.05 | 1.67 | 3.58 | 6.04 | -0.16 | |||
| Total Shareholders' Equity | 275.19M | 40.92M | 61.50M | 103.30M | 53.10M | |||
| TOTAL LIABILITIES AND EQUITY | 297.00M | 50.70M | 70.60M | 109.00M | 56.20M | |||
| Statistics | ||||||||
| Current Ratio | 15.97 | 5.14 | 7.93 | 20.07 | 17.87 | |||
| Return On Assets (ROA) | -25.70% | -107.35% | -62.25% | -25.50% | -25.62% | |||
| Return On Equity (ROE) | -27.74% | -132.99% | -71.46% | -26.91% | -27.12% | |||
All data in USD , ROIC based on taxRate of 0.21